289 related articles for article (PubMed ID: 32429997)
1. ERα-36 regulates progesterone receptor activity in breast cancer.
Konan HP; Kassem L; Omarjee S; Surmieliova-Garnès A; Jacquemetton J; Cascales E; Rezza A; Trédan O; Treilleux I; Poulard C; Le Romancer M
Breast Cancer Res; 2020 May; 22(1):50. PubMed ID: 32429997
[TBL] [Abstract][Full Text] [Related]
2. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor splice variants as a potential source of false-positive estrogen receptor status in breast cancer diagnostics.
Groenendijk FH; Zwart W; Floore A; Akbari S; Bernards R
Breast Cancer Res Treat; 2013 Aug; 140(3):475-84. PubMed ID: 23912957
[TBL] [Abstract][Full Text] [Related]
4. Contemporary evaluation of estrogen receptor and progesterone receptor expression in breast cancer-associated stroma.
Moreno GA; Molina MI; Eastwood D; Auer PL; Jorns JM
Breast Cancer Res Treat; 2022 Dec; 196(3):453-461. PubMed ID: 36208382
[TBL] [Abstract][Full Text] [Related]
5. Receptor conversion in distant breast cancer metastases.
Hoefnagel LD; van de Vijver MJ; van Slooten HJ; Wesseling P; Wesseling J; Westenend PJ; Bart J; Seldenrijk CA; Nagtegaal ID; Oudejans J; van der Valk P; van der Groep P; de Vries EG; van der Wall E; van Diest PJ
Breast Cancer Res; 2010; 12(5):R75. PubMed ID: 20863372
[TBL] [Abstract][Full Text] [Related]
6. FGF2 induces breast cancer growth through ligand-independent activation and recruitment of ERα and PRBΔ4 isoform to MYC regulatory sequences.
Giulianelli S; Riggio M; Guillardoy T; Pérez Piñero C; Gorostiaga MA; Sequeira G; Pataccini G; Abascal MF; Toledo MF; Jacobsen BM; Guerreiro AC; Barros A; Novaro V; Monteiro FL; Amado F; Gass H; Abba M; Helguero LA; Lanari C
Int J Cancer; 2019 Oct; 145(7):1874-1888. PubMed ID: 30843188
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor alpha-negative and progesterone receptor-positive breast cancer: lab error or real entity?
Kiani J; Khan A; Khawar H; Shuaib F; Pervez S
Pathol Oncol Res; 2006; 12(4):223-7. PubMed ID: 17189985
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
[TBL] [Abstract][Full Text] [Related]
9. Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis.
Schrijver WAME; Suijkerbuijk KPM; van Gils CH; van der Wall E; Moelans CB; van Diest PJ
J Natl Cancer Inst; 2018 Jun; 110(6):568-580. PubMed ID: 29315431
[TBL] [Abstract][Full Text] [Related]
10. Crosstalk between progesterone receptor membrane component 1 and estrogen receptor α promotes breast cancer cell proliferation.
Pedroza DA; Subramani R; Tiula K; Do A; Rashiraj N; Galvez A; Chatterjee A; Bencomo A; Rivera S; Lakshmanaswamy R
Lab Invest; 2021 Jun; 101(6):733-744. PubMed ID: 33903732
[TBL] [Abstract][Full Text] [Related]
11. Progesterone receptor modulates ERα action in breast cancer.
Mohammed H; Russell IA; Stark R; Rueda OM; Hickey TE; Tarulli GA; Serandour AA; Birrell SN; Bruna A; Saadi A; Menon S; Hadfield J; Pugh M; Raj GV; Brown GD; D'Santos C; Robinson JL; Silva G; Launchbury R; Perou CM; Stingl J; Caldas C; Tilley WD; Carroll JS
Nature; 2015 Jul; 523(7560):313-7. PubMed ID: 26153859
[TBL] [Abstract][Full Text] [Related]
12. A novel culture method that sustains ERα signaling in human breast cancer tissue microstructures.
Cartaxo AL; Estrada MF; Domenici G; Roque R; Silva F; Gualda EJ; Loza-Alvarez P; Sflomos G; Brisken C; Alves PM; André S; Brito C
J Exp Clin Cancer Res; 2020 Aug; 39(1):161. PubMed ID: 32807212
[TBL] [Abstract][Full Text] [Related]
13. Effect of macrophages on breast cancer cell proliferation, and on expression of hormone receptors, uPAR and HER-2.
Lindsten T; Hedbrant A; Ramberg A; Wijkander J; Solterbeck A; Eriksson M; Delbro D; Erlandsson A
Int J Oncol; 2017 Jul; 51(1):104-114. PubMed ID: 28498427
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor, progesterone receptor, interleukin-6 and interleukin-8 are variable in breast cancer and benign stem/progenitor cell populations.
Schillace RV; Skinner AM; Pommier RF; O'Neill S; Muller PJ; Naik AM; Hansen JE; Pommier SJ
BMC Cancer; 2014 Sep; 14():733. PubMed ID: 25269750
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters.
Giulianelli S; Vaqué JP; Soldati R; Wargon V; Vanzulli SI; Martins R; Zeitlin E; Molinolo AA; Helguero LA; Lamb CA; Gutkind JS; Lanari C
Cancer Res; 2012 May; 72(9):2416-27. PubMed ID: 22396492
[TBL] [Abstract][Full Text] [Related]
16. Association of poor prognosis subtypes of breast cancer with estrogen receptor alpha methylation in Iranian women.
Izadi P; Mehrdad N; Foruzandeh F; Reza NM
Asian Pac J Cancer Prev; 2012; 13(8):4113-7. PubMed ID: 23098526
[TBL] [Abstract][Full Text] [Related]
17. [Expression of estrogen receptor, progesterone receptor, and human epithelial growth factor receptor 2 in breast cancer and the significance thereof: analysis of 910 cases].
Liu RB; Zhou XH; Wang JN; Liang HZ; Li XX; Wu ZH; Ye JL; Wang SM
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3397-400. PubMed ID: 19159568
[TBL] [Abstract][Full Text] [Related]
18. Elevated expression of FREM1 in breast cancer indicates favorable prognosis and high-level immune infiltration status.
Li HN; Li XR; Lv ZT; Cai MM; Wang G; Yang ZF
Cancer Med; 2020 Dec; 9(24):9554-9570. PubMed ID: 33058542
[TBL] [Abstract][Full Text] [Related]
19. STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas.
Chan SR; Vermi W; Luo J; Lucini L; Rickert C; Fowler AM; Lonardi S; Arthur C; Young LJ; Levy DE; Welch MJ; Cardiff RD; Schreiber RD
Breast Cancer Res; 2012 Jan; 14(1):R16. PubMed ID: 22264274
[TBL] [Abstract][Full Text] [Related]
20. Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy.
Bieche I; Parfait B; Le Doussal V; Olivi M; Rio MC; Lidereau R; Vidaud M
Cancer Res; 2001 Feb; 61(4):1652-8. PubMed ID: 11245479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
